Jerome Windsor - Median Technologies Insider

Median Technologies SA -- France Stock  

EUR 10.47  0.02  0.19%

Vice President - Business Development Pharma

Mr. Jerome Windsor has served as Vice President Business Development Pharma at Median Technologies SA. He was former Vice President of commercial development and Strategic Partners of i3, UnitedHealth group subsidiary dedicated to Clinical Research and has over 16 years experience in pharmaceutical, biotech and CRO industries. He previously was European Development Manager at Covance, Cerep, and Consultant at Pricewaterhousecoopers and Accenture
33 4 93 33 37 77
Windsor is cofounder of ANS Biotech, a research company specialized in pain pharmacology. He is Pharm.D. and holds a MBA from ESSEC French Business School.

Management Efficiency

The company has return on total asset (ROA) of (14.44) % which means that it has lost $14.44 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (28.04) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 459 K in total debt with debt to equity ratio (D/E) of 1.1 which is about average as compared to similar companies. Median Technologies SA has Current Ratio of 7.63 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 6 records


Christophe BailleulMauna Kea Technologies SA
Christopher TihanskyMauna Kea Technologies SA
Bruno VillaretMauna Kea Technologies SA
Guillaume BailliardMauna Kea Technologies SA
Jamie MilasEOS imaging SA
Eric MaulaveEOS imaging SA

Entity Summary

MEDIAN Technologies S.A. offer medical imaging solutions and services for diagnosing and monitoring cancer patients in routine clinical practice and clinical drug development. Median Technologies SA (ALMDT) is traded on Paris Stock Exchange in France. It is located in Valbonne, and employs 87 people.

Did you try this?

Run Price Exposure Probability Now

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
Hide  View All  Next  Launch Price Exposure Probability
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Median Technologies SA to your portfolio

Top Management

Median Technologies SA Leadership Team
Fredrik Brag, Chairman
Gerard Milhiet, Director
Michael Auffret, VP
Jacques Souquet, Director, Ph.D
Franck Lescure, Director, MBA
Arnaud Butzbach, Founder
Oran Muduroglu, Director
Jeanne Hecht, COO, MBA
Nicholas Campbell, Executive, MBA
Jerome Windsor, President, MBA
Souhil Zaim, Director
Takashi Mori, Director, MBA
Dennis Atkinson, Director
Bernard Reymann, CFO

Stock Performance

Median Technologies Performance Indicators